# Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis

> **NCT01362504** · — · COMPLETED · sponsor: **Zekai Tahir Burak Women's Health Research and Education Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01362504
- **Lead sponsor:** Zekai Tahir Burak Women's Health Research and Education Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01362504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01362504, "Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01362504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*